IGA NEPHROPATHY

Clinical trials for IGA NEPHROPATHY explained in plain language.

Never miss a new study

Get alerted when new IGA NEPHROPATHY trials appear

Sign up with your email to follow new studies for IGA NEPHROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 2 Not yet finished but already full! 3 Completed 5 Terminated 1

Drug trial aims to halt silent kidney killer

Disease control Terminated

This study tested whether the drug OMS721 (narsoplimab) could slow the progression of IgA nephropathy, a kidney disease. It involved about 360 adults with confirmed disease and high levels of protein in their urine. The main goal was to see if the drug could significantly reduce …

Matched conditions: IGA NEPHROPATHY

Phase: PHASE3 • Sponsor: Omeros Corporation • Aim: Disease control

Last updated Mar 20, 2026 14:48 UTC

IGA NEPHROPATHY

Get alerted when new IGA NEPHROPATHY trials appear

Drug trial aims to halt silent kidney killer